4 month Min+Fin progress (topical) Progress Pictures 6/19/2024
A user shared their 4-month progress using a topical solution with 5% minoxidil and 0.1% finasteride, applied twice daily. They reported good results despite occasional missed applications.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity Started Sept 2023 – Age 36 – Oral Fin + Minoxidil once a day
The user has been using oral finasteride and topical minoxidil since September 2023, experiencing heavy shedding but seeing progress. They also use ketoconazole shampoo and briefly tried a topical finasteride + minoxidil solution, which seemed to worsen their hair density.
community 1mg oral fin and 1.25mg oral min every night and ketoconazole shampoo once or twice a week based on scalp condition.
The user is using 1mg oral finasteride, 1.25mg oral minoxidil nightly, and ketoconazole shampoo weekly for hair loss, reporting no side effects. They self-prescribed after inconsistent use of topical minoxidil, using Lonitab from Intas pharmaceutical.
community 20M, 6 months on topical Min + Fin
A 20-year-old is using a regimen of 5% Minoxidil, 0.1% Finasteride topical solution, derma rolling, and ketoconazole shampoo for hair loss, experiencing some regrowth but also shedding. They are considering increasing derma roller size and possibly adding oral Finasteride or dutasteride for better results.
community Almost 7 months of Topical Fin + Min
A 24-year-old shared their 7-month progress using a topical solution of finasteride 0.1%, minoxidil 5%, and hydrocortisone butyrate 0.08%, along with ketoconazole shampoo, to treat hair loss, reporting no side effects and noticeable hair improvement. They also take vitamin D and biotin supplements, use a dermastamp, and manage Hashimoto's without thyroid medication.
community 2 month progress shots topical min/fin
A user shared their positive experience with a hair loss treatment using a compounded topical solution of Minoxidil, finasteride, tretinoin, and caffeine, along with ketoconazole shampoo, pumpkin seed oil, zinc, biotin, and microneedling. They reported noticeable hair regrowth and no negative side effects.
community Why Is My Hair Thinner All Over After 8 Months on Topical Fin?
The user is experiencing diffuse hair thinning after 8 months on topical finasteride and 11 months on minoxidil, and is considering switching to oral finasteride due to lack of effectiveness. They also mention scalp itchiness and use of a 1% ketoconazole shampoo.
Related Research
6 / 6 resultsresearch Topical solutions for androgenetic alopecia: evaluating efficacy and safety
This review evaluates various topical treatments for androgenetic alopecia but does not provide new clinical findings, emphasizing the need for selecting therapies with limited systemic side effects.
research Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men
This study found that combining oral finasteride with topical minoxidil resulted in the greatest improvement in hair growth for male patients with androgenetic alopecia, compared to using any single treatment.
research Medical Therapy for Female Pattern Hair Loss (FPHL)
This commentary explores the challenges and considerations in treating female pattern hair loss, with no new clinical findings reported.
research Minoxidil: a comprehensive review
This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.
research Overactive bladder in men
This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.
research Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
This study reported that while no effective treatment exists for frontal fibrosing alopecia, oral 5-alpha-reductase inhibitors showed the most promise, inducing a good clinical response in 45% of patients.